Currently out of the existing stock ratings of Roanna Ruiz, 62 are a BUY (66.67%), 31 are a HOLD (33.33%).

Roanna Ruiz

Work Performance Price Targets & Ratings Chart

Analyst Roanna Ruiz, carries an average stock price target met ratio of 45.99% that have a potential upside of 37.56% achieved within 188 days.

Roanna Ruiz’s has documented 175 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on XERS, Xeris Pharmaceuticals at 09-Sep-2026.

Wall Street Analyst Roanna Ruiz

Analyst best performing recommendations are on SCPH (SCPHARMACEUTICALS).
The best stock recommendation documented was for SCPH (SCPHARMACEUTICALS) at 9/9/2021. The price target of $6 was fulfilled within 1 day with a profit of $0.17 (2.76%) receiving and performance score of 27.55.

Average potential price target upside

VIR Vir Biotechnology AMRN Amarin PLC AQST Aquestive Therapeutics CRMD CorMedix CYTK Cytokinetics ENTA Enanta Pharmaceuticals MNKD MannKind Corp MYOV Myovant Sciences Ltd NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares PRDS Pardes Biosciences SPRY ARS Pharmaceuticals TRVI Trevi Therapeutics XERS Xeris Pharmaceuticals ALGS Aligos Therapeutics ARDX Ardelyx AVIR Atea Pharmaceuticals LNTH Lantheus Holdings SCPH Scpharmaceuticals UTHR United Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Feb-2026

$27

$16.97 (169.19%)

$24

3 months 27 days ago
(11-Jun-2026)

0/5 (0%)

$18.48 (216.90%)

Buy Since 14-Sep-2022

$21

$10.97 (109.37%)

$20

4 months 5 days ago
(03-Jun-2026)

0/6 (0%)

$12.23 (139.45%)

Buy Since 21-Sep-2020

$20

$9.97 (99.40%)

$15

7 months 4 days ago
(04-Mar-2026)

1/9 (11.11%)

$10.44 (109.21%)

128

Buy Since 11-Mar-2021

$18

$7.97 (79.46%)

$14

7 months 14 days ago
(24-Feb-2026)

0/19 (0%)

$8.51 (89.67%)

Buy Since 03-Sep-2025

$18

$7.97 (79.46%)

$12

7 months 14 days ago
(24-Feb-2026)

0/2 (0%)

$8.51 (89.67%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Roanna Ruiz most bullish on?

Potential upside of $19.93 has been obtained for SPRY (ARS PHARMACEUTICALS)

Which stock is Roanna Ruiz most reserved on?

Potential downside of $5.93 has been obtained for XERS (XERIS PHARMACEUTICALS)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?